Pfizer launches Immunization Pilot Program for its COVID-19 Vaccine

The Pfizer vaccine which is 94.5% effective will be available in New Mexico, Rhode Island, Tennessee and Texas.



Pfizer Inc., which is co-developing a coronavirus vaccine with BioNTech, has launched a pilot delivery program to implement the COVID-19 Immunization Pilot Program. The move would help the drugmaker refine the plan for delivery and deployment of its COVID-19 vaccine candidate, BNT162b2, when it is authorized by the U.S. Food and Drug Administration.

The four U.S. states include New Mexico, Rhode Island, Tennessee and Texas. These states were picked due to their size, diversity of population, immunization infrastructure and the reach of people in both rural and urban settings. It should be noted that these states will not receive Pfizer vaccine doses earlier than other states by virtue of this pilot, nor will they receive the differential consideration.

Immunization Pilot Program Pfizer vaccine BNT162b2 Moderna Operation Warp Speed

Pfizer expects to adapt learnings from the Immunization Pilot Program for usage across other states in order to help them effectively roll out immunization programs for the coronavirus vaccine.

“We are hopeful that results from this vaccine delivery pilot will serve as the model for other U.S. states and international governments, as they prepare to implement effective COVID-19 vaccine programs,” Pfizer said in a statement on Monday.

Pfizer’s COVID-19 Immunization Pilot Program

Pfizer’s pilot delivery program for its experimental COVID-19 vaccine may face several logistics challenges. First and foremost, Pfizer’s vaccine must be shipped and stored at -70 degrees Celsius (minus 94F), which is significantly below the standard for vaccines of 2-8 degrees Celsius (36-46F).

The drugmaker expects to have enough safety data on the coronavirus vaccine from the ongoing large scale late-stage trials by the third week of November before filing for emergency-use authorization (EUA).

Pfizer expects to adapt learnings from the Immunization Pilot Program for usage across other states in order to help them effectively roll out immunization programs for the coronavirus vaccine.

In order to distribute the Pfizer vaccine, the drugmaker has been working alongside U.S. officials in Operation Warp Speed and the U.S. Centers for Disease Control and Prevention.

The safety data of the COVID-19 vaccine is expected to be available by the next week after which Pfizer and BioNTech plan to seek emergency-use authorization from the US FDA.

Pfizer and its partner BioNTech have inked a $1.95 billion deal to supply 100 million doses of the COVID vaccine to the U.S. government. This may go up to an additional 500 million doses as required.

Earlier on Monday, Pfizer’s rival Moderna Inc. said its COVID-19 vaccine was 94.5% effective in preventing novel coronavirus.

Both Pfizer and Moderna vaccines use a new technology called synthetic messenger RNA to trigger the immune system in creating antibodies against the virus, and that too without causing the infection.

As of November 17, 7 a.m. ET, global cases have research 54,814,867, according to John Hopkins University in Baltimore. The worldwide death toll has hit 1,322, 963.

Anna Domanska
Anna Domanska is an Industry Leaders Magazine author possessing wide-range of knowledge for Business News. She is an avid reader and writer of Business and CEO Magazines and a rigorous follower of Business Leaders.

Recent Posts

Cryptocurrency Scammers Promise Fake Amazon Tokens to Rob Buyers

Cryptocurrency Scammers Promise Fake Amazon Tokens to Rob Buyers

A report by blockchain data platform Chainalysis reveals that nearly $14 billion in cryptocurrency were sent to illicit addresses in 2021.
12 hours ago
Neuralink Looks for a Clinical Trial Director to Direct Its Next Step

Neuralink Looks for a Clinical Trial Director to Direct Its Next Step

Musk had previously revealed that he hopes the company will be able to address a wide range of neurological problems – ranging from addiction to paralysis.
1 day ago
Winter Olympics 2022: The Silence of the Brands

Winter Olympics 2022: The Silence of the Brands

Brands see the Olympics as an opportunity to connect with their consumers and boost sales with limited edition products.
2 days ago
Best Fintech Stocks to Buy in 2022

Best Fintech Stocks to Buy in 2022

The biggest names on Wall Street are buying some of these best fintech stocks of the year. Now maybe a great chance to invest money in the right business.
3 days ago
The Untold Story of How Elon Musk Ousted Tesla’s Founders

The Untold Story of How Elon Musk Ousted Tesla’s Founders

Not many know that Tesla wasn’t founded by Elon Musk. So who founded the world’s most valuable automotive company?
3 days ago
What’s the new inflation rate saying?

What’s the new inflation rate saying?

According to the US consumer price index, the inflation rate has witnessed a rapid rise during the past six months since it’s 0.8% increase in November.
4 days ago